Satellos Bioscience (TSX:MSCL) Days Payable: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:MSCL Satellos Bioscience Inc TSX:MSCL
35 GF Score
Price C$12.85
! 1 Warning Sign
View Full Analysis

What is Satellos Bioscience Days Payable?

Satellos Bioscience TSX:MSCL -5.03% 35 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates TSX:MSCL with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 701 Biotechnology companies, Satellos Bioscience ranks worse than 142653.21% on this metric.

Satellos Bioscience's average Accounts Payable for the three months ended in Mar. 2026 was C$2.67 Mil. Satellos Bioscience's Cost of Goods Sold for the three months ended in Mar. 2026 was C$0.00 Mil.

The historical rank and industry rank for Satellos Bioscience's Days Payable or its related term are showing as below:

During the past 6 years, Satellos Bioscience's highest Days Payable was 1919.29. The lowest was 960.92. And the median was 1440.11.

TSX:MSCL's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Satellos Bioscience's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Satellos Bioscience Days Payable Historical Data

* Premium members only.

The historical data trend for Satellos Bioscience's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Satellos Bioscience Days Payable Chart

Satellos Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 1,919.29 0.00 0.00 0.00 0.00

Satellos Bioscience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSX:MSCL vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Satellos Bioscience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's Days Payable distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's Days Payable falls into.


TSX:MSCL
35GF Score
Satellos Bioscience Inc TSX:MSCL
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Satellos Bioscience Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Satellos Bioscience's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (2.939 + 2.444) / 2 ) / 0*365
=2.6915 / 0*365
=N/A

Satellos Bioscience's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (2.444 + 2.896) / 2 ) / 0*365 / 4
=2.67 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Satellos Bioscience (TSX:MSCL) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Satellos Bioscience and its competitors. Over the past decade, Satellos Bioscience's Days Payable has ranged from 960.92 to 1,919.29. According to the industry distribution chart, Satellos Bioscience ranks #999999 out of 701 companies in the Biotechnology industry.
Is Satellos Bioscience's Days Payable too high?
Satellos Bioscience's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 960.92 to a high of 1,919.29. Based on the distribution chart, Satellos Bioscience ranks #999999 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Satellos Bioscience has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Satellos Bioscience's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Satellos Bioscience ranks #999999 out of 701 companies for Days Payable. This places Satellos Bioscience in the lower half of its industry. The industry median Days Payable is 112.84. Historically, Satellos Bioscience's own Days Payable has ranged from 960.92 to 1,919.29 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Satellos Bioscience and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Satellos Bioscience's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Satellos Bioscience stock overvalued right now?
Satellos Bioscience (TSX:MSCL) has a current Days Payable of 0.00. The current Days Payable is 0.00. Satellos Bioscience's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Satellos Bioscience (TSX:MSCL), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Satellos Bioscience Business Description

Other Exchanges MSLE:USA0IT:Germany
Address 200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
35GF Score

Get the complete analysis for TSX:MSCL

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$12.85
Price